BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9417330)

  • 1. [Study by the Professional Organization of German Transfusion Physicians on epidemiology of HIV- and hepatitis infections in blood donors].
    Glück D; Maurer C; Kubanek B
    Beitr Infusionsther Transfusionsmed; 1997; 34():1-4. PubMed ID: 9417330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Routine PCR screening for HBV, HCV and HIV-I genome in a large blood donation services--experiences and initial results].
    Schottstedt V; Tuma W; Bünger G; Lakenberg P
    Beitr Infusionsther Transfusionsmed; 1997; 34():21-5. PubMed ID: 9417342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
    CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-hepatitis C prevalence and incidence in 2.8 million blood donors in Lower Saxony--residual transfusion-associated HCV risk].
    Diekamp U; Kamutzky K; Windel CD
    Beitr Infusionsther Transfusionsmed; 1997; 34():5-10. PubMed ID: 9417352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
    Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP;
    Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated risk of transmission of hepatitis C virus by blood transfusion.
    Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
    Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
    Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
    Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
    Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of positive hepatitis B, hepatitis C, and HIV serology in cornea donors prescreened by medical and social history in Ontario, Canada.
    Armstrong SA; Gangam N; Chipman ML; Rootman DS
    Cornea; 1997 Sep; 16(5):512-6. PubMed ID: 9294680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current data on the prevalence and epidemiology of HIV from the HIV study by the German Red Cross of West Germany].
    Glück D; Kubanek B; Gaus W; Elbert G; Grässmann W; Hesse R; Holzberger G; Koerner K; Peichl-Hoffmann G; Richter K
    Infusionstherapie; 1990 Jun; 17(3):160-2. PubMed ID: 2391174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003.
    Niederhauser C; Schneider P; Fopp M; Ruefer A; Lévy G
    Euro Surveill; 2005 Feb; 10(2):14-6. PubMed ID: 15735314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria.
    Fasola FA; Kotila TR; Akinyemi JO
    Intervirology; 2008; 51(6):427-31. PubMed ID: 19321928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HIV, HCV, HBV and syphilis infections among blood donors in Germany 2005. Report from the Robert Koch Institute in accordance with Article 22 of the Transfusion Act].
    Offergeld R; Ritter S; Hamouda O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Oct; 50(10):1221-31. PubMed ID: 17924066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis C virus (HCV) antibodies in German blood donors--a pilot study].
    Seidl S; Kühnl P; Beyer J; Stangel W; Flik J; Sibrowski W; Roos D; Bornhövd K; Kalmar G; Flacke H
    Beitr Infusionsther; 1990; 26():18-21. PubMed ID: 2177676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.